Latest filing published 09 Jan 2018 for Oncternal Therapeutics, Inc., €17k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Marc Steven Hanover: trading record in brief
All filings by Marc Steven Hanover on record concern Oncternal Therapeutics, Inc. The record holds 25 filings, for trades running from 14 March 2007 to 5 January 2018.
The open-market side counts 16 purchases for €130k alongside 3 sales for €3.9M. The net balance comes to €3.8M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants. Since January 2018: no purchases and 2 sales on the market.
The median purchase comes to €7,500. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 9 January 2018, reports an open-market sale of €17k in Oncternal Therapeutics, Inc. The last insider purchase was made public on 26 January 2016, 3,940 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marc Steven Hanover
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,681 shares@ US$12.026.5% of flowCommon StockSEC:0001179110-18-000781:0
- 5,628 shares@ US$11.1320.0% of flowCommon StockSEC:0001179110-18-000781:1
- 6,397 shares@ US$12.7126.1% of flowCommon StockSEC:0001179110-18-000403:0
- 123,456 shares@ US$0.8134.9% of flowCommon StockSEC:0001179110-16-030748:0
- 4,000 shares@ US$0.657.4% of flowCommon StockSEC:0001179110-16-017994:0Canonical exit: 25 Apr 2016 (T+90)
- 12,813 shares@ US$0.629622.9% of flowCommon StockSEC:0001179110-16-017981:0Canonical exit: 24 Apr 2016 (T+90)
- 25,000 shares@ US$0.497135.0% of flowCommon StockSEC:0001179110-16-017834:0Canonical exit: 18 Apr 2016 (T+90)
- 2,900 shares@ US$0.47483.9% of flowCommon StockSEC:0001179110-16-017754:1Canonical exit: 13 Apr 2016 (T+90)
- 22,100 shares@ US$0.492730.8% of flowCommon StockSEC:0001179110-16-017754:0Canonical exit: 14 Apr 2016 (T+90)
- 750,000 shares0Common StockSEC:0001179110-15-003065:0
- 227,273 sharesCommon StockSEC:0001179110-14-016763:0
- 5,000 shares@ US$0.75Common StockSEC:0001179110-14-014415:0Canonical exit: 22 Dec 2014 (T+90)
- 10,000 shares@ US$0.7432Common StockSEC:0001179110-14-014247:0Canonical exit: 16 Dec 2014 (T+90)
- 10,000 shares@ US$1.00Common StockSEC:0001179110-14-013095:0Canonical exit: 18 Nov 2014 (T+90)
- 10,000 shares@ US$1.00Common StockSEC:0001179110-14-013095:1Canonical exit: 19 Nov 2014 (T+90)
- 1,652 shares@ US$1.00Common StockSEC:0001179110-14-013030:0Canonical exit: 13 Nov 2014 (T+90)
- 8,348 shares@ US$1.01Common StockSEC:0001179110-14-013030:1Canonical exit: 17 Nov 2014 (T+90)
- 20,000 shares@ US$0.9174Common StockSEC:0001179110-14-012596:0Canonical exit: 5 Nov 2014 (T+90)
- 10,000 shares@ US$0.9532Common StockSEC:0001179110-14-012596:1Canonical exit: 6 Nov 2014 (T+90)
- 30,000 shares@ US$0.9202Common StockSEC:0001179110-14-012557:0Canonical exit: 5 Nov 2014 (T+90)
- 250,000 sharesCommon StockSEC:0001209191-09-010768:0
- 1,000 shares@ US$10.75Common StockSEC:0001209191-09-005844:0Canonical exit: 29 Apr 2009 (T+90)
- 2,000 shares@ US$10.54Common StockSEC:0001209191-09-005084:0Canonical exit: 27 Apr 2009 (T+90)
- 217,027 sharesCommon StockSEC:0001209191-07-069966:0
- 228,700 shares@ US$22.10Common StockSEC:0001209191-07-017689:0
25 of 25 declarations
